We are live on ! Find out more
MD icon

Pediatrix Medical

264 hedge funds and large institutions have $1.16B invested in Pediatrix Medical in 2025 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 88 increasing their positions, 90 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

89% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 27

10% more funds holding

Funds holding: 241264 (+23)

0.46% more ownership

Funds ownership: 93.41%93.88% (+0.46%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% less capital invested

Capital invested by funds: $1.16B → $1.16B (-$4.09M)

2% less repeat investments, than reductions

Existing positions increased: 88 | Existing positions reduced: 90

Holders
264
Holders Change
+23
Holders Change %
+9.54%
% of All Funds
3.48%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
51
Increased
88
Reduced
90
Closed
27
Calls
$1.2M
Puts
Net Calls
+$1.2M
Net Calls Change
-$1.36M
Name Holding Trade Value Shares
Change
Change in
Stake
SBH
26
Segall Bryant & Hamill
Illinois
$9.31M -$1.18M -86,109 -12%
Citadel Advisors
27
Citadel Advisors
Florida
$9.23M +$4.98M +362,848 +129%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$8.69M -$49K -3,576 -0.6%
Invesco
29
Invesco
Georgia
$8.53M -$3.69M -269,090 -31%
ACH
30
ArrowMark Colorado Holdings
Colorado
$8.46M -$2.77M -201,909 -26%
Nomura Holdings
31
Nomura Holdings
Japan
$8.28M +$4.34M +316,274 +121%
BCM
32
Bridgeway Capital Management
Texas
$8.25M +$280K +20,433 +4%
BIP
33
Brandes Investment Partners
California
$8.11M -$1.71M -124,946 -18%
Bank of America
34
Bank of America
North Carolina
$8.09M -$415K -30,297 -5%
Point72 Asset Management
35
Point72 Asset Management
Connecticut
$7.9M +$7.55M +550,843 New
OAM
36
Oberweis Asset Management
Illinois
$7.83M
PAM
37
Panagora Asset Management
Massachusetts
$7.46M +$2.24M +162,988 +46%
ACB
38
Aristotle Capital Boston
Massachusetts
$7.05M -$532K -38,778 -7%
EF
39
Empowered Funds
Pennsylvania
$6.97M +$2.69M +196,129 +68%
BNP Paribas Financial Markets
40
BNP Paribas Financial Markets
France
$6.83M +$5.68M +414,216 +669%
Principal Financial Group
41
Principal Financial Group
Iowa
$6.54M -$1.79M -130,473 -22%
UBS Group
42
UBS Group
Switzerland
$5.91M +$3.71M +270,255 +191%
UBS AM
43
UBS AM
Illinois
$5.85M +$1.91M +139,357 +52%
AQR Capital Management
44
AQR Capital Management
Connecticut
$5.59M -$877K -63,953 -14%
HIM
45
Hillsdale Investment Management
Ontario, Canada
$5.4M +$5.16M +376,000 +75,200%
BGIM
46
Brandywine Global Investment Management
Pennsylvania
$5.31M +$5.07M +370,041 New
GLA
47
Great Lakes Advisors
Illinois
$4.78M +$4.56M +332,846 New
Millennium Management
48
Millennium Management
New York
$4.73M +$3.4M +248,049 +303%
LSV Asset Management
49
LSV Asset Management
Illinois
$4.28M +$690K +50,304 +20%
CSS
50
Cubist Systematic Strategies
Connecticut
$4.25M +$4.06M +296,061 New

MD Hedge Fund Activity: Q2 2025 in Review

264 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q2 2025, worth a combined $1.16B — down 0.35% from $1.16B a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new MD positions and 27 closed out — a net gain of 24 holders — while 88 added to existing stakes and 90 trimmed.

The largest buyer was Victory Capital Management, adding an estimated $42.4M. The largest seller was AllianceBernstein, cutting an estimated $68.8M.

  • 264 institutional investors held Pediatrix Medical (MD) as of Q2 2025, up from 241 in Q1 2025.
  • Funds reported $1.16B of Pediatrix Medical stock for Q2 2025, down 0.35% quarter-over-quarter.
  • 51 funds opened new Pediatrix Medical positions in Q2 2025 and 27 closed out, a net change of +24 holders.
  • The largest Pediatrix Medical buyer in Q2 2025 was Victory Capital Management, an estimated $42.4M added.
  • The largest Pediatrix Medical seller in Q2 2025 was AllianceBernstein, an estimated $68.8M sold.

Based on aggregated 13F filings for Q2 2025.